ANI Pharmaceuticals Inc.

NASDAQ: ANIP · Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT

ANI Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-18.52M 18.78M -47.9M -42.6M
Depreciation & Amortization
67.73M 59.79M 59.65M 47.25M
Stock-Based Compensation
29.34M 20.65M 14.6M 10.49M
Other Working Capital
30.71M 19.79M 4.2M -7.93M
Other Non-Cash Items
18.56M 6.62M 8.99M 5.02M
Deferred Income Tax
-21.91M -11.74M -15.25M -16.75M
Change in Working Capital
-11.19M 24.86M -51.3M -84K
Operating Cash Flow
64.02M 118.96M -31.2M 3.32M
Capital Expenditures
-16.95M -18.51M -16.45M -23.64M
Cash Acquisitions
-401.28M n/a -33K -84.49M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-3.44M -9.64M 750K 2.65M
Investing Cash Flow
-404.72M -18.51M -15.74M -105.48M
Debt Repayment
345.22M -3M -3M 99.02M
Common Stock Repurchased
-10.96M -4.99M -1.96M -890K
Dividend Paid
-1.63M -1.63M -1.63M -190K
Other Financial Acitivies
-67.69M -3.5M 1.46M 2.07M
Financial Cash Flow
264.94M 67.44M -5.13M 194.59M
Net Cash Flow
-76.23M 167.89M -52.07M 92.43M
Free Cash Flow
47.06M 100.45M -47.66M -20.32M